{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T12:35:34Z","timestamp":1793450134346,"version":"4.5.0"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T00:00:00Z","timestamp":1783468800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002329","name":"Federal Office of Public Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002329","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain, Behavior, and Immunity"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.bbi.2026.106892","type":"journal-article","created":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T15:50:37Z","timestamp":1783353037000},"page":"106892","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Temelimab versus placebo in patients with post-COVID condition"],"prefix":"10.1016","volume":"138","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9189-6495","authenticated-orcid":false,"given":"Mayssam","family":"Nehme","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margret","family":"Hund-Georgiadis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther Del","family":"Corral Beamonte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre-Olivier","family":"Bridevaux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Hoepner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iris-Katharina","family":"Penner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joana","family":"Strobel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory","family":"Fretz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Merc\u00e8 Boada","family":"Rovira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesc","family":"Puchades","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Landi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo Guisado","family":"Vasco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Guaraldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco Mera","family":"Cordero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Sebastianelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loredana","family":"Sarmati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Berthuy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e9r\u00f4me","family":"Wojcik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karim","family":"Keddad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anke","family":"Post","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Leppert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0491-6089","authenticated-orcid":false,"given":"Idris","family":"Guessous","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbi.2026.106892_b0005","unstructured":"Abdelnabi, M., Saleh, Y., Ahmed, A., Benjanuwattra, J., Leelaviwat, N., Almaghraby, A., 2023. Ivabradine effects on COVID-19-associated postural orthostatic tachycardia syndrome: a single center prospective study. Am. J. Cardiovasc. Dis. Jun 25;13(3):162-167. PMID: 37469536; PMCID: PMC10352820."},{"key":"10.1016\/j.bbi.2026.106892_b0010","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1126\/science.adl0867","article-title":"Solving the puzzle of Long Covid","volume":"383","author":"Al-Aly","year":"2024","journal-title":"Science"},{"key":"10.1016\/j.bbi.2026.106892_b0015","doi-asserted-by":"crossref","unstructured":"Ameringer, S., Elswick, R.K. Jr, Menzies, V., Robins, J.L., Starkweather, A., Walter, J., Gentry, A.E., Jallo, N., 2016. Psychometric evaluation of the patient-reported outcomes measurement information system fatigue-short form across diverse populations. Nurs. Res. Jul-Aug;65(4):279-89. doi: 10.1097\/NNR.0000000000000162. PMID: 27362514; PMCID: PMC4930004.","DOI":"10.1097\/NNR.0000000000000162"},{"issue":"3","key":"10.1016\/j.bbi.2026.106892_b0020","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1093\/cid\/ciae205","article-title":"Assessment of the impact of RNase in patients with severe fatigue related to post-acute sequelae of SARS-CoV-2 infection: a randomized phase 2 trial of RSLV-132","volume":"79","author":"Andrews","year":"2024","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.bbi.2026.106892_b0025","unstructured":"Bach, K. New data shows long Covid is keeping as many as 4 million people out of work. Aug 24, 2022. Brookings Institute. Available: https:\/\/www.brookings.edu\/articles\/new-data-shows-long-covid-is-keeping-as-many-as-4-million-people-out-of-work\/ [Accessed May 05, 2024]."},{"key":"10.1016\/j.bbi.2026.106892_b0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2021.103341","article-title":"Evidence of the pathogenic HERV-W envelope expression in T lymphocytes in association with the respiratory outcome of COVID-19 patients","volume":"66","author":"Balestrieri","year":"2021","journal-title":"EBioMedicine"},{"key":"10.1016\/j.bbi.2026.106892_b0035","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1126\/science.6189183","article-title":"Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS)","volume":"220","author":"Barr\u00e9-Sinoussi","year":"1983","journal-title":"Science"},{"key":"10.1016\/j.bbi.2026.106892_b0040","doi-asserted-by":"crossref","unstructured":"Benedict, R.H., DeLuca, J., Phillips, G., LaRocca, N., Hudson, L.D., Rudick, R.; Multiple Sclerosis Outcome Assessments Consortium. Validity of the Symbol Digit Modalities Test as a cognition performance outcome measure for multiple sclerosis. Mult. Scler. Apr;23(5):721-733. doi: 10.1177\/1352458517690821. Epub 2017 Feb 16. PMID: 28206827; PMCID: PMC5405816.","DOI":"10.1177\/1352458517690821"},{"key":"10.1016\/j.bbi.2026.106892_b0045","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2021.745758","article-title":"Long COVID 19 syndrome: is it related to microcirculation and endothelial dysfunction? Insights from TUN-EndCOV study","volume":"8","author":"Charfeddine","year":"2021","journal-title":"Front. Cardiovasc. Med."},{"key":"10.1016\/j.bbi.2026.106892_b0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2023.106604","article-title":"SARS-CoV-2 awakens ancient retroviral genes and the expression of proinflammatory HERV-W envelope protein in COVID-19 patients","volume":"26","author":"Charvet","year":"2023","journal-title":"iScience"},{"key":"10.1016\/j.bbi.2026.106892_b0055","doi-asserted-by":"crossref","unstructured":"Charvet, B., Lucas, A., Pierquin, J., et al., Blood biomarkers-defined subgroups show heterogeneity in post-acute COVID-19 syndrome: a rationale for precision medicine. medRxiv 2023:2023.03.31.23288003.","DOI":"10.1101\/2023.03.31.23288003"},{"key":"10.1016\/j.bbi.2026.106892_b0060","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.64909","article-title":"Convalescent COVID-19 patients are susceptible to endothelial dysfunction due to persistent immune activation","volume":"10","author":"Chioh","year":"2021","journal-title":"Elife"},{"key":"10.1016\/j.bbi.2026.106892_b0065","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1126\/science.aad5497","article-title":"Regulatory evolution of innate immunity through co-option of endogenous retroviruses","volume":"351","author":"Chuong","year":"2016","journal-title":"Science"},{"issue":"6599","key":"10.1016\/j.bbi.2026.106892_b0070","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1126\/science.add4297","article-title":"Clues to long COVID","volume":"376","author":"Couzin-Frankel","year":"2022","journal-title":"Science"},{"issue":"6692","key":"10.1016\/j.bbi.2026.106892_b0075","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1126\/science.adp7205","article-title":"Lessons in persistence","volume":"384","author":"Couzin-Frankel","year":"2024","journal-title":"Science"},{"key":"10.1016\/j.bbi.2026.106892_b0080","doi-asserted-by":"crossref","first-page":"265","DOI":"10.4161\/19420862.2014.985021","article-title":"Preclinical and early clinical development of GNbAC1, a humanized IgG4 monoclonal antibody targeting endogenous retroviral MSRV-Env protein","volume":"7","author":"Curtin","year":"2015","journal-title":"MAbs"},{"key":"10.1016\/j.bbi.2026.106892_b0085","doi-asserted-by":"crossref","unstructured":"Davis, H.E., Assaf, G.S., McCorkell, L., Wei, H., Low, R.J., Re\u2019em, Y., Redfield, S., Austin, J.P., Akrami, A., Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine. 2021 Aug; 38:101019. doi: 10.1016\/j.eclinm.2021.101019. Epub 2021 Jul 15. PMID: 34308300; PMCID: PMC8280690.","DOI":"10.1016\/j.eclinm.2021.101019"},{"key":"10.1016\/j.bbi.2026.106892_b0090","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1038\/s41579-023-00896-0","article-title":"Author correction: long COVID: major findings, mechanisms and recommendations","volume":"21","author":"Davis","year":"2023","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.bbi.2026.106892_b0095","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/S1473-3099(23)00440-1","article-title":"Where are the long COVID trials?","volume":"23","author":"Diseases","year":"2023","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.bbi.2026.106892_b0100","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/nrg3199","article-title":"Endogenous viruses: insights into viral evolution and impact on host biology","volume":"13","author":"Feschotte","year":"2012","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.bbi.2026.106892_b0105","doi-asserted-by":"crossref","unstructured":"Finnigan, L.E.M., Cassar, M.P., Koziel, M.J., Pradines, J., Lamlum, H., Azer, K., Kirby, D., Montgomery, H., Neubauer, S., Valkovi\u010d, L., Raman, B., 2023. Efficacy and tolerability of an endogenous metabolic modulator (AXA1125) in fatigue-predominant long COVID: a single-centre, double-blind, randomised controlled phase 2a pilot study. EClinicalMedicine. May;59:101946. doi: 10.1016\/j.eclinm.2023.101946. Epub 2023 Apr 14. PMID: 37223439; PMCID: PMC10102537.","DOI":"10.1016\/j.eclinm.2023.101946"},{"key":"10.1016\/j.bbi.2026.106892_b0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2021.103363","article-title":"HERV-W envelope expression in blood leukocytes as a marker of disease severity of COVID-19","volume":"67","author":"Garcia-Montojo","year":"2021","journal-title":"EBioMedicine"},{"issue":"9","key":"10.1016\/j.bbi.2026.106892_b0115","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1001\/jamainternmed.2024.2007","article-title":"Nirmatrelvir-ritonavir and symptoms in adults with postacute sequelae of SARS-CoV-2 infection: the STOP-PASC randomized clinical trial","volume":"184","author":"Geng","year":"2024","journal-title":"JAMA Intern. Med."},{"key":"10.1016\/j.bbi.2026.106892_b0120","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1020064","article-title":"HERV-W ENV antigenemia and correlation of increased anti-SARS-CoV-2 immunoglobulin levels with post-COVID-19 symptoms","volume":"13","author":"Gim\u00e9nez-Orenga","year":"2022","journal-title":"Front. Immunol."},{"issue":"48","key":"10.1016\/j.bbi.2026.106892_b0125","article-title":"Blood parameters differentiate post COVID-19 condition from myalgic encephalomyelitis\/chronic fatigue syndrome and fibromyalgia","volume":"4","author":"Gim\u00e9nez-Orenga","year":"2025","journal-title":"Brain Behav. Immun. Health"},{"key":"10.1016\/j.bbi.2026.106892_b0130","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.3389\/fimmu.2018.02039","article-title":"Human endogenous retroviruses are ancient acquired elements still shaping innate immune responses","volume":"9","author":"Grandi","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbi.2026.106892_b0135","doi-asserted-by":"crossref","unstructured":"Herdman, M., Gudex, C., Lloyd, A., Janssen, M., Kind, P., Parkin, D., Bonsel, G., Badia, X., 2011. Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Qual Life Res. Dec;20(10):1727-36. doi: 10.1007\/s11136-011-9903-x. Epub 2011 Apr 9. PMID: 21479777; PMCID: PMC3220807.","DOI":"10.1007\/s11136-011-9903-x"},{"issue":"36","key":"10.1016\/j.bbi.2026.106892_b0140","article-title":"Low-dose naltrexone and NAD+ for the treatment of patients with persistent fatigue symptoms after COVID-19","volume":"1","author":"Isman","year":"2024","journal-title":"Brain Behav. Immun. Health"},{"issue":"2\u20133","key":"10.1016\/j.bbi.2026.106892_b0145","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.schres.2003.09.011","article-title":"The brief assessment of cognition in schizophrenia: reliability, sensitivity, and comparison with a standard neurocognitive battery","volume":"68","author":"Keefe","year":"2004","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.bbi.2026.106892_b0150","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01494-2020","article-title":"The post-COVID-19 functional status scale: a tool to measure functional status over time after COVID-19","volume":"56","author":"Klok","year":"2020","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.bbi.2026.106892_b0155","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1177\/1352458514560926","article-title":"The neutralizing antibody GNbAC1 abrogates HERV-W envelope protein-mediated oligodendroglial maturation blockade","volume":"21","author":"Kremer","year":"2015","journal-title":"Mult. Scler."},{"key":"10.1016\/j.bbi.2026.106892_b0160","doi-asserted-by":"crossref","first-page":"15216","DOI":"10.1073\/pnas.1901283116","article-title":"pHERV-W envelope protein fuels microglial cell-dependent damage of myelinated axons in multiple sclerosis","volume":"116","author":"Kremer","year":"2019","journal-title":"PNAS"},{"issue":"9","key":"10.1016\/j.bbi.2026.106892_b0165","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1046\/j.1525-1497.2001.016009606.x","article-title":"The PHQ-9: validity of a brief depression severity measure","volume":"16","author":"Kroenke","year":"2001","journal-title":"J. Gen. Intern. Med."},{"key":"10.1016\/j.bbi.2026.106892_b0170","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1038\/d41586-022-02140-w","article-title":"Long-COVID treatments: why the world is still waiting","volume":"608","author":"Ledford","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.bbi.2026.106892_b0175","doi-asserted-by":"crossref","first-page":"12730","DOI":"10.1021\/acs.chemrev.6b00125","article-title":"Retroviral DNA integration","volume":"116","author":"Lesbats","year":"2016","journal-title":"Chem. Rev."},{"key":"10.1016\/j.bbi.2026.106892_b0180","unstructured":"Lezak, M.D., 2004. Neuropsychological Assessment: Oxford University Press."},{"key":"10.1016\/j.bbi.2026.106892_b0185","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jneuroim.2015.12.006","article-title":"MSRV envelope protein is a potent, endogenous and pathogenic agonist of human toll-like receptor 4: Relevance of GNbAC1 in multiple sclerosis treatment","volume":"291","author":"Madeira","year":"2016","journal-title":"J. Neuroimmunol."},{"issue":"3","key":"10.1016\/j.bbi.2026.106892_b0190","article-title":"COVID-19 induced postural orthostatic tachycardia syndrome (POTS): a review","volume":"15","author":"Mallick","year":"2023","journal-title":"Cureus."},{"issue":"3","key":"10.1016\/j.bbi.2026.106892_b0195","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1093\/brain\/awad377","article-title":"Vortioxetine for the treatment of post-COVID-19 condition: a randomized controlled trial","volume":"147","author":"McIntyre","year":"2024","journal-title":"Brain"},{"key":"10.1016\/j.bbi.2026.106892_b0200","doi-asserted-by":"crossref","first-page":"14505","DOI":"10.1038\/s41598-022-18673-z","article-title":"The chronification of post-COVID condition associated with neurocognitive symptoms, functional impairment and increased healthcare utilization","volume":"12","author":"Nehme","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbi.2026.106892_b0205","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1007\/s11606-022-07882-x","article-title":"The prevalence, severity, and impact of post-COVID persistent fatigue, post-exertional malaise, and chronic fatigue syndrome","volume":"38","author":"Nehme","year":"2023","journal-title":"J. Gen. Intern. Med."},{"key":"10.1016\/j.bbi.2026.106892_b0210","doi-asserted-by":"crossref","unstructured":"Patrick-Brown, T.D.J.H., Barratt-Due, A., Tr\u00f8seid, M., Dyrhol-Riise, A.M., Nezvalova-Henriksen, K., K\u00e5sine, T., Aukrust, P., Olsen, I.C.; NOR Solidarity consortium. The effects of remdesivir on long-term symptoms in patients hospitalised for COVID-19: a pre-specified exploratory analysis. Commun. Med. (Lond.) 2024 Nov 12;4(1):231. doi: 10.1038\/s43856-024-00650-4. PMID: 39533001; PMCID: PMC11557865.","DOI":"10.1038\/s43856-024-00650-4"},{"issue":"11","key":"10.1016\/j.bbi.2026.106892_b0215","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1093\/infdis\/jiab490","article-title":"Markers of immune activation and inflammation in individuals with postacute sequelae of severe acute respiratory syndrome coronavirus 2 infection","volume":"224","author":"Peluso","year":"2021","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.bbi.2026.106892_b0220","doi-asserted-by":"crossref","first-page":"7583","DOI":"10.1073\/pnas.94.14.7583","article-title":"Molecular identification of a novel retrovirus repeatedly isolated from patients with multiple sclerosis. The collaborative research group on multiple sclerosis","volume":"94","author":"Perron","year":"1997","journal-title":"PNAS"},{"key":"10.1016\/j.bbi.2026.106892_b0225","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1177\/1352458512441381","article-title":"Human endogenous retrovirus type W envelope expression in blood and brain cells provides new insights into multiple sclerosis disease","volume":"18","author":"Perron","year":"2012","journal-title":"Mult. Scler."},{"key":"10.1016\/j.bbi.2026.106892_b0230","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1038\/s41590-021-01113-x","article-title":"Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection","volume":"23","author":"Phetsouphanh","year":"2022","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.bbi.2026.106892_b0235","doi-asserted-by":"crossref","first-page":"7415","DOI":"10.1073\/pnas.77.12.7415","article-title":"Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma","volume":"77","author":"Poiesz","year":"1980","journal-title":"PNAS"},{"key":"10.1016\/j.bbi.2026.106892_b0240","doi-asserted-by":"crossref","first-page":"337","DOI":"10.3109\/07853890109002087","article-title":"EQ-5D: a measure of health status from the EuroQol Group","volume":"33","author":"Rabin","year":"2001","journal-title":"Ann. Med."},{"key":"10.1016\/j.bbi.2026.106892_b0245","unstructured":"RECOVER study. RECOVER-AUTONOMIC clinical trial results shared at 2026 ACC Conference. https:\/\/recovercovid.org\/news\/recover-autonomic-clinical-trial-results-shared-2026-acc-conference [Published March 28, 2026. Last accessed May 13, 2026]."},{"key":"10.1016\/j.bbi.2026.106892_b0250","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s13317-019-0122-8","article-title":"HERV-K and HERV-W transcriptional activity in myalgic encephalomyelitis\/chronic fatigue syndrome","volume":"10","author":"Rodrigues","year":"2019","journal-title":"Auto Immun Highlights"},{"key":"10.1016\/j.bbi.2026.106892_b0255","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/s12967-022-03328-4","article-title":"Autoimmunity is a hallmark of post-COVID syndrome","volume":"20","author":"Rojas","year":"2022","journal-title":"J. Transl. Med."},{"issue":"5","key":"10.1016\/j.bbi.2026.106892_b0260","first-page":"e8224","article-title":"Using generalized anxiety disorder-2 (GAD-2) and GAD-7 in a primary care setting","volume":"12","author":"Sapra","year":"2020","journal-title":"Cureus."},{"issue":"8","key":"10.1016\/j.bbi.2026.106892_b0265","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/S1473-3099(25)00073-8","article-title":"Nirmatrelvir-ritonavir versus placebo-ritonavir in individuals with long COVID in the USA (PAX LC): a double-blind, randomised, placebo-controlled, phase 2, decentralised trial","volume":"25","author":"Sawano","year":"2025","journal-title":"Lancet Infect. Dis."},{"issue":"6","key":"10.1016\/j.bbi.2026.106892_b0270","article-title":"The IL-1\u03b2, IL-6, and TNF cytokine triad is associated with post-acute sequelae of COVID-19","volume":"3","author":"Schulthei\u00df","year":"2022","journal-title":"Cell Rep. Med."},{"issue":"2","key":"10.1016\/j.bbi.2026.106892_b0275","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1097\/YIC.0b013e3282f2b4d6","article-title":"Assessing treatment effects in clinical trials with the discan metric of the Sheehan disability scale","volume":"23","author":"Sheehan","year":"2008","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.bbi.2026.106892_b0280","doi-asserted-by":"crossref","DOI":"10.1128\/jvi.00059-23","article-title":"CancerHERVdb: human endogenous retrovirus (HERV) expression database for human cancer accelerates studies of the retrovirome and predictions for HERV-based therapies","volume":"97","author":"Stricker","year":"2023","journal-title":"J. Virol."},{"key":"10.1016\/j.bbi.2026.106892_b0285","doi-asserted-by":"crossref","unstructured":"Strober, L.B., Binder, A., Nikelshpur, O.M., Chiaravalloti, N., DeLuca, J., 2016. The perceived deficits questionnaire: perception, deficit, or distress? Int. J. MS Care. Jul-Aug;18(4):183-90. doi: 10.7224\/1537-2073.2015-028. PMID: 27551243; PMCID: PMC4984790.","DOI":"10.7224\/1537-2073.2015-028"},{"key":"10.1016\/j.bbi.2026.106892_b0290","unstructured":"World Health Organization. A clinical case definition of post COVID-19 condition by a Delphi consensus. Last updated October 6, 202Available: https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/345824\/WHO-2019-nCoV-Post-COVID-19-condition-Clinical-case-definition-2021.1-eng.pdf [Accessed October 10, 2021]."}],"container-title":["Brain, Behavior, and Immunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889159126006409?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889159126006409?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T12:20:13Z","timestamp":1793449213000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889159126006409"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":58,"alternative-id":["S0889159126006409"],"URL":"https:\/\/doi.org\/10.1016\/j.bbi.2026.106892","relation":{},"ISSN":["0889-1591"],"issn-type":[{"value":"0889-1591","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Temelimab versus placebo in patients with post-COVID condition","name":"articletitle","label":"Article Title"},{"value":"Brain, Behavior, and Immunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbi.2026.106892","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"106892"}}